Cell Therapy for Jet Lag | How New Research Accelerates Recovery

Research into Circadian Rhythm Correction

Disruptions to the body’s internal clock often stem from shifts in time zones or irregular work schedules. These conflicts lead to sleep loss and metabolic instability. Researchers from Rice University and Northwestern University recently developed a potential solution involving an implantable cell therapy. The project received support from the Rice Biotech Launch Pad to investigate how metabolic signaling might influence the human circadian system.

The findings appeared in the journal Advanced Science. The team engineered cells to release leptin, a hormone usually associated with metabolism and appetite control. By placing these cells inside microscopic alginate spheres, the researchers protected the biological material from the host immune system. The spheres allow the hormone to diffuse into the body after a simple subcutaneous injection. This system acts as a temporary intervention before the cells eventually lose viability.

Experimental Results in Animals

Initial testing focused on rodents. When exposed to phase advances and delays, treated mice adjusted to a four-hour schedule shift 50% faster than the control group. This provided the team with evidence that manipulating metabolic pathways could speed up the internal process of resetting the circadian clock.

Following the rodent trials, the team moved to cynomolgus macaques. These non-human primates share more biological similarities with humans regarding sleep-wake patterns. In this group, the therapy reduced the time needed for physical entrainment after a six-hour schedule shift by one full day. Monitoring included tracking heart rate, core body temperature, and physical activity levels to ensure the changes represented a genuine biological shift.

Safety and Future Clinical Potential

Concerns regarding sleep architecture are common in studies of circadian rhythm modulation. The researchers examined total sleep time along with REM and non-REM cycles in the primates. They reported no negative impacts on sleep. Some data even indicated an increase in slow-wave sleep activity, which hints at better recovery quality. Safety monitoring included blood tests and long-term observation to detect signs of toxicity. The team reported no long-term adverse events after one year of follow-up.

This technology addresses a gap in current methods. Conventional strategies, such as melatonin usage or strictly timed light exposure, often fail to produce immediate results. The goal of this research is not to alter the circadian system permanently. Instead, it offers a temporary boost during moments of high stress. Future applications could include assisting shift workers or personnel involved in military operations. The team intends to investigate mechanisms that link leptin more directly to circadian regulation while developing versions of the platform that allow for repeated or tuned support.